Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

ClinicalTrials.gov ID: NCT00772070

Public ClinicalTrials.gov record NCT00772070. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 20, 2026, 1:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Antibody Responses to a Reduced Dose of Menomune® in Children Who Previously Received an Experimental Tetravalent (A, C, Y, and W-135) Meningococcal Diphtheria Toxoid Conjugate Vaccine, TetraMenD

Study identification

NCT ID: NCT00772070
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Enrollment: 173 participants

Conditions and interventions

Conditions

Interventions

A/C/Y/W-135, Meningococcal Polysaccharide Vaccine (Menomune®) Biological

Biological

Eligibility (public fields only)

Age range: 3 Years to 5 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 28, 2003
Primary completion: Jul 31, 2003
Completion: Apr 30, 2004
Last update posted: Feb 13, 2014

2003 – 2004

United States locations

U.S. sites: 8
U.S. states: 6
U.S. cities: 8

Facility	City	State	ZIP	Site status
Not listed	Jonesboro	Arkansas	72401	—
Not listed	Little Rock	Arkansas	72211	—
Not listed	Woburn	Massachusetts	01801	—
Not listed	Bridgeton	Missouri	63044	—
Not listed	Rochester	New York	14620	—
Not listed	Pittsburgh	Pennsylvania	15241	—
Not listed	Sellersville	Pennsylvania	18960	—
Not listed	Norfolk	Virginia	23501	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00772070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 13, 2014 · Synced Jul 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00772070 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →